Enovis ENOV
NYSE ENOV
$26.29 -0.21 (-0.79%)
At close: Aug 20, 2026 · 1:19 PM UTC

Enovis (ENOV) Liabilities and Shareholders Equity (2010 - 2026)

Enovis (ENOV) posted quarterly Liabilities and Shareholders Equity of $3.8 billion for Q2 2026, down 21.39% year-over-year from $4.9 billion in Q2 2025, and little changed quarter-over-quarter from $3.8 billion in Q4 2025.

Enovis (ENOV) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Enovis (ENOV) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $3.8 billion the latest figure, recorded in Q2 2026.

  • In Q2 2026, Liabilities and Shareholders Equity fell 21.39% year-over-year to $3.8 billion; the TTM figure through Apr 2026 stood at $17.1 billion (down 16.83% YoY), while the FY2025 annual figure was $3.8 billion, down 18.73% from the prior year.
  • Liabilities and Shareholders Equity steadied at $3.8 billion in Q2 2026 per ENOV's latest filing, from $3.8 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $5.6 billion in Q3 2024 and bottomed at $1.8 billion in Q2 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $4.5 billion across 5 years, with a median of $4.4 billion in 2022.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity sank 77.69% — and 2023, when it surged 138.87%.
  • Enovis' Liabilities and Shareholders Equity stood at $4.3 billion in 2022, then gained by 5.52% to $4.5 billion in 2023, then increased by 4.64% to $4.7 billion in 2024, then decreased by 18.73% to $3.8 billion in 2025, then slipped by 0.06% to $3.8 billion in 2026.
  • Business Quant data shows ENOV's Liabilities and Shareholders Equity at $3.8 billion in Q2 2026, $3.8 billion in Q4 2025, and $4.4 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn 109.22 Bn
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 31.04 Bn
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 10.74 Bn
10 Enovis 1.52 Bn 1.50 Bn 359.25 Mn 3.77 Bn

Historic Data

Download Data
DateValue
Jul 3, 2026 3.77 Bn
Apr 3, 2026 3.83 Bn
Dec 31, 2025 3.83 Bn
Oct 3, 2025 4.43 Bn
Jul 4, 2025 5.02 Bn
Apr 4, 2025 4.88 Bn
Dec 31, 2024 4.72 Bn
Sep 27, 2024 5.55 Bn
Jun 28, 2024 5.44 Bn
Mar 29, 2024 5.48 Bn
Dec 31, 2023 4.51 Bn
Sep 29, 2023 4.40 Bn
Jun 30, 2023 4.44 Bn
Mar 31, 2023 4.30 Bn
Dec 31, 2022 4.27 Bn
Sep 30, 2022 4.44 Bn
Jul 1, 2022 4.50 Bn
Apr 1, 2022 1.80 Bn
Dec 31, 2021 8.52 Bn
Oct 1, 2021 7.97 Bn